Donners MM et al. |
Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE-/- mice. |
2005 |
Am. J. Transplant. |
pmid:15888024
|
Lemahieu W et al. |
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea. |
2005 |
Am. J. Transplant. |
pmid:15888045
|
Djamali A et al. |
Nox2 is a mediator of chronic CsA nephrotoxicity. |
2012 |
Am. J. Transplant. |
pmid:22568654
|
Campbell PM et al. |
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. |
2007 |
Am. J. Transplant. |
pmid:17456201
|
Saikali JA et al. |
Sirolimus may promote thrombotic microangiopathy. |
2003 |
Am. J. Transplant. |
pmid:12603218
|
Silva HT et al. |
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:24266969
|
Ricciardelli I et al. |
Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. |
2013 |
Am. J. Transplant. |
pmid:24266973
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
McKenna G and Trotter JF |
Does early (CNI) conversion lead to eternal (renal) salvation? |
2010 |
Am. J. Transplant. |
pmid:20928938
|
Shuker N et al. |
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. |
2016 |
Am. J. Transplant. |
pmid:26714287
|
Koefoed-Nielsen PB et al. |
Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. |
2002 |
Am. J. Transplant. |
pmid:12099520
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Willicombe M et al. |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. |
2011 |
Am. J. Transplant. |
pmid:21299828
|
Bohl DL et al. |
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. |
2005 |
Am. J. Transplant. |
pmid:16095500
|
Kasahara M et al. |
Living-donor liver transplantation for hepatoblastoma. |
2005 |
Am. J. Transplant. |
pmid:16095502
|
Lemahieu WP et al. |
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095503
|
Meier-Kriesche HU et al. |
Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095509
|
Senior PA et al. |
Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. |
2005 |
Am. J. Transplant. |
pmid:16095517
|
RodrÃguez-Perálvarez M et al. |
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. |
2013 |
Am. J. Transplant. |
pmid:23621166
|
Vanhove T et al. |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients. |
2017 |
Am. J. Transplant. |
pmid:28224698
|
Madeleine MM et al. |
HPV-related cancers after solid organ transplantation in the United States. |
2013 |
Am. J. Transplant. |
pmid:24119294
|
Bressollette-Bodin C et al. |
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996241
|
Augustine JJ et al. |
Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996247
|
Filler G et al. |
Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. |
2005 |
Am. J. Transplant. |
pmid:15996252
|
Froud T et al. |
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. |
2005 |
Am. J. Transplant. |
pmid:15996257
|
Shihab F et al. |
Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:28141897
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Dahm F et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15575921
|
O'Connell PJ et al. |
Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. |
2013 |
Am. J. Transplant. |
pmid:23668890
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Flechner SM et al. |
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. |
2011 |
Am. J. Transplant. |
pmid:21668635
|
Budde K |
How to use mTOR inhibitors? The search goes on. |
2011 |
Am. J. Transplant. |
pmid:21668636
|
Chen G et al. |
Anti-CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys. |
2007 |
Am. J. Transplant. |
pmid:17227555
|
Maes BD et al. |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12484345
|
Asberg A et al. |
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20486914
|
Hautz T et al. |
Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. |
2010 |
Am. J. Transplant. |
pmid:20353468
|
Silva HT et al. |
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17217442
|
Moench C et al. |
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17511685
|
Patlolla V et al. |
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17564638
|
Nijhoff MF et al. |
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression. |
2016 |
Am. J. Transplant. |
pmid:26288226
|
Lacaille F et al. |
Severe dysimmune cytopenia in children treated with tacrolimus after organ transplantation. |
2006 |
Am. J. Transplant. |
pmid:16611346
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Lefaucheur C et al. |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. |
2008 |
Am. J. Transplant. |
pmid:18671673
|
McDonald RA et al. |
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. |
2008 |
Am. J. Transplant. |
pmid:18416737
|
Triñanes J et al. |
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells. |
2017 |
Am. J. Transplant. |
pmid:28432716
|
Pallet N et al. |
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. |
2016 |
Am. J. Transplant. |
pmid:26990694
|
Chhabra D et al. |
Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen. |
2013 |
Am. J. Transplant. |
pmid:24007570
|